These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 22675662)

  • 1. HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment.
    Spudich S; González-Scarano F
    Cold Spring Harb Perspect Med; 2012 Jun; 2(6):a007120. PubMed ID: 22675662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV pharmacology: barriers to the eradication of HIV from the CNS.
    McGee B; Smith N; Aweeka F
    HIV Clin Trials; 2006; 7(3):142-53. PubMed ID: 16880170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurologic complications of HIV-1 infection and its treatment in the era of antiretroviral therapy.
    Kranick SM; Nath A
    Continuum (Minneap Minn); 2012 Dec; 18(6 Infectious Disease):1319-37. PubMed ID: 23221843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 persistence in the central nervous system: viral and host determinants during antiretroviral therapy.
    Balcom EF; Roda WC; Cohen EA; Li MY; Power C
    Curr Opin Virol; 2019 Oct; 38():54-62. PubMed ID: 31390580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation and HIV-associated neurologic disease.
    Dahiya S; Irish BP; Nonnemacher MR; Wigdahl B
    Adv Virus Res; 2013; 87():183-240. PubMed ID: 23809924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease.
    Arendt G; Nolting T; Frisch C; Husstedt IW; Gregor N; Koutsilieri E; Maschke M; Angerer A; Obermann M; Neuen-Jacob E; Adams O; Loeffert S; Riederer P; ter Meulen V; Sopper S;
    J Neurovirol; 2007 Jun; 13(3):225-32. PubMed ID: 17613712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-associated neurological disorders: a guide to pharmacotherapy.
    Tan IL; McArthur JC
    CNS Drugs; 2012 Feb; 26(2):123-34. PubMed ID: 22201342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS.
    Minagar A; Commins D; Alexander JS; Hoque R; Chiappelli F; Singer EJ; Nikbin B; Shapshak P
    Mol Diagn Ther; 2008; 12(1):25-43. PubMed ID: 18288880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF penetration by antiretroviral drugs.
    Eisfeld C; Reichelt D; Evers S; Husstedt I
    CNS Drugs; 2013 Jan; 27(1):31-55. PubMed ID: 23160938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible dementia in a patient with central nervous system escape of human immunodeficiency virus.
    Bogoch II; Davis BT; Venna N
    J Infect; 2011 Sep; 63(3):236-9. PubMed ID: 21658774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in clinical neurosciences: The neuropathogenesis of HIV infection: host-virus interaction and the impact of therapy.
    Power C; Gill MJ; Johnson RT
    Can J Neurol Sci; 2002 Feb; 29(1):19-32. PubMed ID: 11858531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of HIV-1 drug resistance in the neurological compartment.
    Antinori A; Cingolani A; Giancola ML; Forbici F; De Luca A; Perno CF
    Scand J Infect Dis Suppl; 2003; 106():41-4. PubMed ID: 15000582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment.
    Chan P; Brew BJ
    Curr HIV/AIDS Rep; 2014 Sep; 11(3):317-24. PubMed ID: 24966139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developments in HIV neuropathogenesis.
    Rumbaugh JA; Nath A
    Curr Pharm Des; 2006; 12(9):1023-44. PubMed ID: 16515484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment.
    Smit TK; Brew BJ; Tourtellotte W; Morgello S; Gelman BB; Saksena NK
    J Virol; 2004 Sep; 78(18):10133-48. PubMed ID: 15331746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurologic complications of HIV infection.
    Spudich SS; Ances BM
    Top Antivir Med; 2012; 20(2):41-7. PubMed ID: 22710906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral infections of the central nervous system: pathogenesis to therapeutics.
    Soldan SS; Jacobson S
    J Neuroimmune Pharmacol; 2010 Sep; 5(3):267-70. PubMed ID: 20658202
    [No Abstract]   [Full Text] [Related]  

  • 18. Cognitive Impairment and Persistent CNS Injury in Treated HIV.
    Chan P; Hellmuth J; Spudich S; Valcour V
    Curr HIV/AIDS Rep; 2016 Aug; 13(4):209-17. PubMed ID: 27188299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of HIV in the CNS: effects of antiretroviral therapy and the promise of non-antiretroviral therapeutics.
    Peluso MJ; Spudich S
    Curr HIV/AIDS Rep; 2014 Sep; 11(3):353-62. PubMed ID: 25063356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV infection of the central nervous system: clinical features and neuropathogenesis.
    Boissé L; Gill MJ; Power C
    Neurol Clin; 2008 Aug; 26(3):799-819, x. PubMed ID: 18657727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.